6092 EnBio Holdings,Inc - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6092

TSE Standard

EnBio Holdings,Inc

580

JPY

-6

(-1.02%)

Dec 23, 3:10 pm JST

3.70

USD

Dec 23, 1:10 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	6,840	617	592	304	46.2	0	May 14, 2021	J-GAAP
Mar, 2022	8,987	1,229	1,197	654	98.5	8	May 13, 2022	J-GAAP
Mar, 2023	8,120	1,357	1,343	812	122.3	8	May 15, 2023	J-GAAP
Mar, 2024	9,575	815	1,067	708	88.9	8	May 15, 2024	J-GAAP
Mar, 2025 Guidance	10,913	818	674	450	55.7	8	Nov 14, 2024	J-GAAP
YoY	+14.0%	+0.4%	-36.8%	-36.4%	-37.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 15, 2019	9,237	840	607	345	0	J-GAAP
	Aug 9, 2019	9,237	840	607	523	0	J-GAAP
	Feb 14, 2020	7,448	732	551	531	0	J-GAAP
Results	May 15, 2020	7,408	674	521	555	0	J-GAAP
Mar, 2021	May 15, 2020	Available in future release
	Feb 12, 2021
	May 13, 2021
Results	May 14, 2021
Mar, 2022	May 14, 2021
	Aug 13, 2021
	Feb 14, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	Aug 12, 2022
	Nov 14, 2022
Results	May 15, 2023
Mar, 2024	May 15, 2023
	Feb 14, 2024
	May 8, 2024
Results	May 15, 2024
Mar, 2025	May 15, 2024	10,762	604	508	340	8	J-GAAP
	Nov 14, 2024	10,913	818	674	450	8	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2009	86	－	Available in future release
Mar, 2010	28	-67.4
Mar, 2011	38	+35.7
Mar, 2012	1,396	+3,573.7
Mar, 2013	1,493	+6.9
Mar, 2014	2,108	+41.2
Mar, 2015	1,979	-6.1
Mar, 2016	2,732	+38.0
Mar, 2017	5,347	+95.7
Mar, 2018	8,388	+56.9
Mar, 2019	8,563	+2.1
Mar, 2020	7,408	-13.5
Mar, 2021	6,840	-7.7
Mar, 2022	8,987	+31.4
Mar, 2023	8,120	-9.6
Mar, 2024	9,575	+17.9
Mar, 2025 Guidance	10,913	+14.0	818	+0.4	674	-36.8	55.7	-37.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	8,120	1,357	16.7	12.81	4.82	0.48	122.3
Mar, 2024	9,575	815	8.51	9.27	3.86	0.52	88.9
Mar, 2025 Guidance	10,913	818	7.50	4.88	2.14	0.52	55.7

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	9,575	1,357	1,343	812	2,200.0
Fiscal Year	Mar, 2024	Mar, 2023	Mar, 2023	Mar, 2023	Mar, 2013

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	4,686	527	523	279	42.0	8	May 13, 2022	J-GAAP
Oct - Mar, 2022	2,484	-21	-186	-160	-24.1	8	May 15, 2023	J-GAAP
Oct - Mar, 2023	4,093	406	519	387	48.6	8	May 15, 2024	J-GAAP
Oct - Mar, 2024 Guidance	4,954	46	35	35	4.3	8	Nov 14, 2024	J-GAAP
YoY	+21.0%	-88.7%	-93.3%	-91.0%	-91.1%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	1,229	932	2,413	-1,481	-534	2,341	14.30	J-GAAP
Mar, 2023	1,357	219	1,989	-1,770	240	2,798	16.13	J-GAAP
Mar, 2024	815	80	1,663	-1,583	638	3,574	18.51	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	5,636	1,378	1,529	972	146.4	113.8	Nov 14, 2022	J-GAAP
Apr - Sep, 2023	5,482	409	548	321	41.1	51.4	Nov 14, 2023	J-GAAP
Apr - Sep, 2024	5,959	772	639	415	51.2	94.8	Nov 14, 2024	J-GAAP
YoY	+8.7%	+88.8%	+16.6%	+29.3%	+24.6%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	1,135	-18	-161	-116	-17.5	-1.6	Feb 13, 2023	J-GAAP
Jan - Mar, 2023	1,349	-3	-25	-44	-6.6	-0.2	May 15, 2023	J-GAAP
Apr - Jun, 2023	3,423	240	345	170	22.8	7.0	Aug 14, 2023	J-GAAP
Jul - Sep, 2023	2,059	169	203	151	19.3	8.2	Nov 14, 2023	J-GAAP
Oct - Dec, 2023	1,504	58	-2	24	3.0	3.9	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	2,589	348	521	363	45.6	13.4	May 15, 2024	J-GAAP
Apr - Jun, 2024	2,997	395	513	351	43.3	13.2	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	2,962	377	126	64	7.9	12.7	Nov 14, 2024	J-GAAP
YoY	+43.9%	+123.1%	-37.9%	-57.6%	-59.2%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	1,460	-42.1	Available in future release
Jan - Mar, 2020	1,661	-18.6
Apr - Jun, 2020	2,371	+10.1
Jul - Sep, 2020	1,250	-41.4
Oct - Dec, 2020	1,870	+28.1
Jan - Mar, 2021	1,349	-18.8
Apr - Jun, 2021	1,921	-19.0
Jul - Sep, 2021	2,380	+90.4
Oct - Dec, 2021	3,039	+62.5
Jan - Mar, 2022	1,647	+22.1
Apr - Jun, 2022	2,668	+38.9
Jul - Sep, 2022	2,968	+24.7
Oct - Dec, 2022	1,135	-62.7
Jan - Mar, 2023	1,349	-18.1
Apr - Jun, 2023	3,423	+28.3
Jul - Sep, 2023	2,059	-30.6
Oct - Dec, 2023	1,504	+32.5
Jan - Mar, 2024	2,589	+91.9
Apr - Jun, 2024	2,997	-12.4
Jul - Sep, 2024	2,962	+43.9	377	+123.1	126	-37.9	7.9	-59.1

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,423	715	810	492	74.1
Fiscal Year	Jun, 2023	Jun, 2022	Jun, 2022	Sep, 2022	Sep, 2022

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	886.12	36.0	16,370	5,888	2,352	1.46	May 13, 2022	J-GAAP
Mar, 2023	1,022.70	39.1	17,349	6,788	3,111	1.31	May 15, 2023	J-GAAP
Mar, 2024	1,043.91	44.0	19,310	8,494	3,761	1.01	May 15, 2024	J-GAAP
Apr - Sep, 2024	1,142.00	44.0	20,992	9,229	4,112	1.05	Nov 14, 2024	J-GAAP

EnBio Holdings,Inc(6092) Financial Results